Lee's Pharm: Unicycive Therapeutics : Announces Exclusive License and Development Agreement with Lee's Pharmaceutical Holdings Limited for Renazorb in China and Certain Other Asian Markets - Form 8-K

(marketscreener.com) Unicycive Announces Exclusive License and Development Agreement with Lee's Pharmaceutical Holdings Limited for Renazorb in China and Certain Other Asian Markets Expands and accelerates Renazorb opportunity in important markets for patients with hyperphosphatemia through local partner with deep domain expertise ...https://www.marketscreener.com/quote/stock/UNICYCIVE-THERAPEUTICS-I-123776316/news/Unicycive-Therapeutics-Announces-Exclusive-License-and-Development-Agreement-with-Lee-s-Pharmaceut-41014791/?utm_medium=RSS&utm_content=20220718